USA Financial Formulas’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-910
| Closed | -$956K | – | 354 |
|
|
2024
Q2 | $956K | Buy |
910
+58
| +7% | +$61K | 0.16% | 79 |
|
|
2024
Q1 | $820K | Buy |
+852
| New | +$820K | 0.13% | 86 |
|
|
2023
Q4 | – | Sell |
-2,695
| Closed | -$2.22M | – | 502 |
|
|
2023
Q3 | $2.22M | Sell |
2,695
-17
| -0.6% | -$14K | 3.32% | 4 |
|
|
2023
Q2 | $1.95M | Sell |
2,712
-1,276
| -32% | -$917K | 2.99% | 7 |
|
|
2023
Q1 | $3.28M | Buy |
+3,988
| New | +$3.28M | 5.31% | 4 |
|
|
2022
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 269 |
|
|
2022
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 295 |
|
|
2022
Q1 | $1K | Sell |
1
-2,618
| -100% | -$2.62M | ﹤0.01% | 327 |
|
|
2021
Q4 | $1.65M | Buy |
2,619
+2,613
| +43,550% | +$1.65M | 1.42% | 16 |
|
|
2021
Q3 | $4K | Buy |
+6
| New | +$4K | ﹤0.01% | 285 |
|
|
2020
Q4 | – | Sell |
-4,304
| Closed | -$2.41M | – | 401 |
|
|
2020
Q3 | $2.41M | Sell |
4,304
-2,982
| -41% | -$1.67M | 1.82% | 18 |
|
|
2020
Q2 | $4.54M | Sell |
7,286
-174
| -2% | -$109K | 3.38% | 5 |
|
|
2020
Q1 | $3.64M | Buy |
+7,460
| New | +$3.64M | 2.32% | 6 |
|
|
2019
Q3 | – | Sell |
-16,517
| Closed | -$6.78M | – | 252 |
|
|
2019
Q2 | $6.78M | Buy |
16,517
+3,587
| +28% | +$1.47M | 3.4% | 13 |
|
|
2019
Q1 | $5.31M | Buy |
12,930
+11,705
| +956% | +$4.81M | 3.34% | 15 |
|
|
2018
Q4 | $495K | Buy |
+1,225
| New | +$495K | 0.12% | 125 |
|
|
2018
Q3 | – | Sell |
-1,143
| Closed | -$394K | – | 379 |
|
|
2018
Q2 | $394K | Sell |
1,143
-9
| -0.8% | -$3.1K | 0.1% | 187 |
|
|
2018
Q1 | $397K | Buy |
+1,152
| New | +$397K | 0.1% | 185 |
|
|
2017
Q4 | – | Sell |
-8,030
| Closed | -$3.59M | – | 325 |
|
|
2017
Q3 | $3.59M | Buy |
+8,030
| New | +$3.59M | 0.86% | 36 |
|
|
2015
Q4 | – | Sell |
-13,895
| Closed | -$6.46M | – | 121 |
|
|
2015
Q3 | $6.46M | Buy |
+13,895
| New | +$6.46M | 4.19% | 9 |
|